|Bid||5.70 x 1200|
|Ask||5.71 x 900|
|Day's Range||5.60 - 5.90|
|52 Week Range||2.86 - 7.45|
|Beta (5Y Monthly)||1.36|
|PE Ratio (TTM)||9.30|
|Earnings Date||May 07, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.45|
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its first quarter 2021 financial results on Friday, May 7, 2021, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on May 7, 2021.
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Amneal Pharmaceuticals, Inc. (NYSE: AMRX).
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...